News

Richard Freed

Richard provides strategic vision and manages daily business activities. While at Dupont for over a decade, he led biotech venture launches, consulted for healthcare management, and oversaw M&A transactions. For instance, he was Venture Manager for the largest joint venture in DuPont’s Industrial Biotech portfolio, a $200M+ JV with BP that created gene-edited yeast cells to produce isobutane rather than ethanol.